Ultraviolet light therapy may help reduce inflammation and disease severity in people with MS, according to data from a small ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

A new study out of the United States could shift how multiple sclerosis (MS) is detected and treated. Researchers say they’ve ...

ALBUQUERQUE, N.M. (AP) — It’s a name many people have trouble pronouncing, but these synthetic chemicals have been used in everything from fast-food packaging to nonstick cookware, clothing, household ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. The blood test, which ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of ...